Measurement of copy number variation in single cancer cells using rapid-emulsification digital droplet MDA

od Kim, Samuel C., Premasekharan, Gayatri, Clark, Iain C., Gemeda, Hawi B., Paris, Pamela L., Abate, Adam R.
Izdano u Microsyst Nanoeng (2017)

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

od Anantharaman, Archana, Friedlander, Terence, Lu, David, Krupa, Rachel, Premasekharan, Gayatri, Hough, Jeffrey, Edwards, Matthew, Paz, Rosa, Lindquist, Karla, Graf, Ryon, Jendrisak, Adam, Louw, Jessica, Dugan, Lyndsey, Baird, Sarah, Wang, Yipeng, Dittamore, Ryan, Paris, Pamela L.
Izdano u BMC Cancer (2016)

Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer

od Alva, Ajjai, Friedlander, Terence, Clark, Melanie, Huebner, Tamara, Daignault, Stephanie, Hussain, Maha, Lee, Cheryl, Hafez, Khaled, Hollenbeck, Brent, Weizer, Alon, Premasekharan, Gayatri, Tran, Tony, Fu, Christine, Ionescu-Zanetti, Cristian, Schwartz, Michael, Fan, Andrea, Paris, Pamela
Izdano u J Urol (2015)

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer

od Su, Yang, Liu, Yue, Behrens, Christopher R., Bidlingmaier, Scott, Lee, Nam-Kyung, Aggarwal, Rahul, Sherbenou, Daniel W., Burlingame, Alma L., Hann, Byron C., Simko, Jeffry P., Premasekharan, Gayatri, Paris, Pamela L., Shuman, Marc A., Seo, Youngho, Small, Eric J., Liu, Bin
Izdano u JCI Insight (2018)